Richard Paulson
2021
In 2021, Richard Paulson earned a total compensation of $8.4M as President and Chief Executive Officer at Karyopharm Therapeutics.
Compensation breakdown
| Bonus | $300,000 |
|---|---|
| Non-Equity Incentive Plan | $435,500 |
| Option Awards | $3,563,575 |
| Salary | $468,365 |
| Stock Awards | $3,523,008 |
| Other | $64,724 |
| Total | $8,355,172 |
Paulson received $3.6M in option awards, accounting for 43% of the total pay in 2021.
Paulson also received $300K in bonus, $435.5K in non-equity incentive plan, $468.4K in salary, $3.5M in stock awards and $64.7K in other compensation.
Rankings
In 2021, Richard Paulson's compensation ranked 1,365th out of 12,415 executives tracked by ExecPay. In other words, Paulson earned more than 89.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,365 out of 12,415 | 89th |
Division Manufacturing | 491 out of 5,505 | 91st |
Major group Chemicals And Allied Products | 180 out of 2,375 | 92nd |
Industry group Drugs | 150 out of 2,096 | 93rd |
Industry Pharmaceutical Preparations | 99 out of 1,546 | 94th |
Source: SEC filing on April 8, 2022.
Paulson's colleagues
We found five more compensation records of executives who worked with Richard Paulson at Karyopharm Therapeutics in 2021.
2021
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
2021
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
2021
Michael Mason
Karyopharm Therapeutics
Chief Financial Officer
2021
Jatin Shah
Karyopharm Therapeutics
Chief Medical Officer
2021
Ran Frenkel
Karyopharm Therapeutics